Summit Therapeutics Inc.
SMMT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $15 | $16 | $14 | $13 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $15 | $16 | $14 | $13 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$1 | -$0 | -$0 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$1 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.31 | -0.76 | -0.085 | -0.083 |
| % Growth | 59.2% | -792% | -2.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |